186 related articles for article (PubMed ID: 36948086)
41. Automated pathway and reaction prediction facilitates in silico identification of unknown metabolites in human cohort studies.
Quell JD; Römisch-Margl W; Colombo M; Krumsiek J; Evans AM; Mohney R; Salomaa V; de Faire U; Groop LC; Agakov F; Looker HC; McKeigue P; Colhoun HM; Kastenmüller G
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Dec; 1071():58-67. PubMed ID: 28479069
[TBL] [Abstract][Full Text] [Related]
42. Global metabolic profiling using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Qi Y; Song Y; Gu H; Fan G; Chai Y
Methods Mol Biol; 2014; 1198():15-27. PubMed ID: 25270920
[TBL] [Abstract][Full Text] [Related]
43. Metabolomic approaches for enzyme function and pathway discovery in bacteria.
Hubert CB; de Carvalho LPS
Methods Enzymol; 2022; 665():29-47. PubMed ID: 35379439
[TBL] [Abstract][Full Text] [Related]
44. Serum amino acid metabolic profiles of ankylosing spondylitis by targeted metabolomics analysis.
Zhou Y; Zhang X; Chen R; Han S; Liu Y; Liu X; Gao M; Yang C; Lu D; Sun B; Chen H
Clin Rheumatol; 2020 Aug; 39(8):2325-2336. PubMed ID: 32130577
[TBL] [Abstract][Full Text] [Related]
45. Comparative Metabolomics Revealing the Metabolic Responses of Pathogenic Bacteria to Different Antibiotics.
Choueiry F; Sun X; Zhu J
Methods Mol Biol; 2021; 2296():367-380. PubMed ID: 33977459
[TBL] [Abstract][Full Text] [Related]
46. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
47. Multi Platforms Strategies and Metabolomics Approaches for the Investigation of Comprehensive Metabolite Profile in Dogs with
Rubić I; Burchmore R; Weidt S; Regnault C; Kuleš J; Barić Rafaj R; Mašek T; Horvatić A; Crnogaj M; Eckersall PD; Novak P; Mrljak V
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163517
[TBL] [Abstract][Full Text] [Related]
48. Unveiling Microbial Chemical Interactions Based on Metabolomics Approaches.
de Carvalho LC; de Almeida Junior A; Ribeiro FS; Angolini CFF
Adv Exp Med Biol; 2023; 1439():51-70. PubMed ID: 37843805
[TBL] [Abstract][Full Text] [Related]
49. Overlap in serum metabolic profiles between non-related diseases: Implications for LC-MS metabolomics biomarker discovery.
Lindahl A; Forshed J; Nordström A
Biochem Biophys Res Commun; 2016 Sep; 478(3):1472-7. PubMed ID: 27581198
[TBL] [Abstract][Full Text] [Related]
50. A Metabolomic Approach to Understanding the Metabolic Link between Obesity and Diabetes.
Park S; Sadanala KC; Kim EK
Mol Cells; 2015 Jul; 38(7):587-96. PubMed ID: 26072981
[TBL] [Abstract][Full Text] [Related]
51. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
Gu Y; Zang P; Li J; Yan Y; Wang J
Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
[TBL] [Abstract][Full Text] [Related]
52. Advances in mass spectrometry based single-cell metabolomics.
Duncan KD; Fyrestam J; Lanekoff I
Analyst; 2019 Jan; 144(3):782-793. PubMed ID: 30426983
[TBL] [Abstract][Full Text] [Related]
53. Application of pathways activity profiling to urine metabolomics for screening Qi-tonifying biomarkers and metabolic pathways of honey-processed Astragalus.
Liu W; Li C; Huang J; Liao J; Liao S; Ma W; Chen H; Rui W
J Sep Sci; 2018 Jun; 41(12):2661-2671. PubMed ID: 29570937
[TBL] [Abstract][Full Text] [Related]
54. Mass spectrometry based metabolomics and enzymatic assays for functional genomics.
Baran R; Reindl W; Northen TR
Curr Opin Microbiol; 2009 Oct; 12(5):547-52. PubMed ID: 19695948
[TBL] [Abstract][Full Text] [Related]
55. Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease.
González-Domínguez R; García-Barrera T; Gómez-Ariza JL
Anal Bioanal Chem; 2014 Nov; 406(28):7137-48. PubMed ID: 25230597
[TBL] [Abstract][Full Text] [Related]
56. Mass-spectrometric profiling of cerebrospinal fluid reveals metabolite biomarkers for CNS involvement in varicella zoster virus reactivation.
Kuhn M; Sühs KW; Akmatov MK; Klawonn F; Wang J; Skripuletz T; Kaever V; Stangel M; Pessler F
J Neuroinflammation; 2018 Jan; 15(1):20. PubMed ID: 29343258
[TBL] [Abstract][Full Text] [Related]
57. The role of metabolomic markers for patients with infectious diseases: implications for risk stratification and therapeutic modulation.
Zurfluh S; Baumgartner T; Meier MA; Ottiger M; Voegeli A; Bernasconi L; Neyer P; Mueller B; Schuetz P
Expert Rev Anti Infect Ther; 2018 Feb; 16(2):133-142. PubMed ID: 29316826
[TBL] [Abstract][Full Text] [Related]
58. Untargeted metabolomics.
Vinayavekhin N; Saghatelian A
Curr Protoc Mol Biol; 2010 Apr; Chapter 30():Unit 30.1.1-24. PubMed ID: 20373502
[TBL] [Abstract][Full Text] [Related]
59. The metabolomic signature of hematologic malignancies.
Allegra A; Innao V; Gerace D; Bianco O; Musolino C
Leuk Res; 2016 Oct; 49():22-35. PubMed ID: 27526405
[TBL] [Abstract][Full Text] [Related]
60. Metabolomic Profiling Identified Serum Metabolite Biomarkers and Related Metabolic Pathways of Colorectal Cancer.
Zhang C; Zhou S; Chang H; Zhuang F; Shi Y; Chang L; Ai W; Du J; Liu W; Liu H; Zhou X; Wang Z; Hong T
Dis Markers; 2021; 2021():6858809. PubMed ID: 34917201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
